Literature DB >> 11731587

Endothelin-1-endothelin receptor type A mediates closure of rat ductus arteriosus at birth.

T Taniguchi1, H Azuma, Y Okada, H Naiki, M D Hollenberg, I Muramatsu.   

Abstract

1. The ductus arteriosus (DA) undergoes rapid closure after birth as pulmonary circulation is established. The involvement of endothelin-1 (ET1) in this closure mechanism is controversial. 2. The effect of ATZ1993 (ATZ), a non-peptide antagonist for the ET(A) and ET(B) receptors, on postnatal closure and O2-induced contraction of the rat DA was investigated both in vivo and in vitro. Rat pups were delivered by Caesarean section and were given ATZ intraperitoneally. The minimum external DA diameter and the extent of DA constriction in vivo were evaluated at 2.5 h after birth. ATZ caused a dose-dependent inhibition of DA closure in vivo. When rat pups were given ATZ at 2.5 h after birth, re-opening of the DA was observed. 3. In vitro, ATZ also caused a marked inhibition of O2-induced and ET1-induced DA contractions as did BQ123, an ET(A)-specific antagonist. In contrast, sarafotoxin S6c, an ET(B)-specific agonist, did not cause DA contraction and BQ788, an ET(B)-specific antagonist, did not affect O2-induced DA contraction. 4. In conclusion, ET1 and its cognate receptor ET(A) may play a physiological role in the postnatal closure of the rat DA in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731587      PMCID: PMC2278969          DOI: 10.1111/j.1469-7793.2001.00579.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  20 in total

1.  Effects of TAK-044, a nonselective endothelin receptor antagonist, on the spontaneous and indomethacin- or methylene blue-induced constriction of the ductus arteriosus in rats.

Authors:  T Takizawa; E Horikoshi; M H Shen; T Masaoka; H Takagi; M Yamamoto; K Kasai; K Arishima
Journal:  J Vet Med Sci       Date:  2000-05       Impact factor: 1.267

2.  Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel.

Authors:  M Tristani-Firouzi; H L Reeve; S Tolarova; E K Weir; S L Archer
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation.

Authors:  C A Mason; J L Bigras; S B O'Blenes; B Zhou; B McIntyre; N Nakamura; Y Kaneda; M Rabinovitch
Journal:  Nat Med       Date:  1999-02       Impact factor: 53.440

Review 4.  The pharmacology of the ductus arteriosus.

Authors:  G C Smith
Journal:  Pharmacol Rev       Date:  1998-03       Impact factor: 25.468

Review 5.  Current therapy of the patent ductus arteriosus.

Authors:  W A Radtke
Journal:  Curr Opin Cardiol       Date:  1998-01       Impact factor: 2.161

6.  Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.

Authors:  E Segi; Y Sugimoto; A Yamasaki; Y Aze; H Oida; T Nishimura; T Murata; T Matsuoka; F Ushikubi; M Hirose; T Tanaka; N Yoshida; S Narumiya; A Ichikawa
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

7.  ATZ1993, an orally active and novel nonpeptide antagonist for endothelin receptors and inhibition of intimal hyperplasia after balloon denudation of the rabbit carotid artery.

Authors:  H Azuma; J Sato; H Masuda; M Goto; S Tamaoki; A Sugimoto; H Hamasaki; H Yamashita
Journal:  Jpn J Pharmacol       Date:  1999-09

Review 8.  Prostaglandin synthetase inhibitors in pregnancy.

Authors:  I B Van den Veyver; K J Moise
Journal:  Obstet Gynecol Surv       Date:  1993-07       Impact factor: 2.347

9.  Endothelin A receptor is necessary for O(2) constriction but not closure of ductus arteriosus.

Authors:  F Coceani; Y Liu; E Seidlitz; L Kelsey; T Kuwaki; C Ackerley; M Yanagisawa
Journal:  Am J Physiol       Date:  1999-10

10.  Endothelin-receptor blockade does not alter closure of the ductus arteriosus.

Authors:  J R Fineman; Y Takahashi; C Roman; R I Clyman
Journal:  Am J Physiol       Date:  1998-11
View more
  4 in total

1.  Endothelin-induced constriction of the ductus venosus in fetal sheep: developmental aspects and possible interaction with vasodilatory prostaglandin.

Authors:  A S O Adeagbo; L Kelsey; F Coceani
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

2.  Current Perspectives on Pathobiology of the Ductus Arteriosus.

Authors:  Jason Z Stoller; Sara B Demauro; John M Dagle; Jeff Reese
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

Review 3.  Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension.

Authors:  Thomas J Monaco; Carlos D Davila
Journal:  Drug Des Devel Ther       Date:  2016-05-18       Impact factor: 4.162

Review 4.  Patent ductus arteriosus and oxidative stress in preterm infants: a narrative review.

Authors:  Carlo Dani; Simone Pratesi
Journal:  Transl Pediatr       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.